Company / Operating Cash Flow
CVS Health Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$10.6B
FY2025
5-year range
$9.1B / $18.3B
FY2021-FY2025
Trend
+16.8%
vs FY2024
Sector context
#3 of 163
Health Care
What the data says
Among 163 Health Care companies, CVS Health is in the top 2% for operating cash flow. Operating Cash Flow has fluctuated over the past 10 years, ranging from $8.0B in FY2017 to $18.3B in FY2023.
Based on SEC 10-K filings.
$10.6B in FY2025 with a 5-year CAGR of +3.7%. Ranks 3rd among 163 companies in Health Care.
Declined from $18.3B to $10.6B over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -13.0%
- 5-Year CAGR
- +3.7%
- 10-Year CAGR
- -
Sector benchmark
+917.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.7%, indicating consistent growth.
- In FY2025, operating cash flow increased 16.8% year-over-year.
- Ranks #3 out of 163 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.6B | +16.8% |
| FY2024 | $9.1B | -50.1% |
| FY2023 | $18.3B | +12.9% |
| FY2022 | $16.2B | +25.9% |
| FY2021 | $12.8B | +44.9% |
| FY2020 | $8.9B | -31.0% |
| FY2019 | $12.8B | +44.9% |
| FY2018 | $8.9B | +10.7% |
| FY2017 | $8.0B | -21.0% |
| FY2016 | $10.1B | +18.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026